<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anaphylaxis during pregnancy and delivery</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anaphylaxis during pregnancy and delivery</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anaphylaxis during pregnancy and delivery</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Schatz, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mitchell P Dombrowski, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce S Bochner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David L Hepner, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Anaphylaxis is defined clinically as "a serious allergic or hypersensitivity reaction that is rapid in onset and may cause death" [<a href="#rid1">1</a>]. In pregnancy, it can be catastrophic for both parent and fetus [<a href="#rid2">2</a>]. This topic will review issues specific to anaphylaxis during pregnancy, delivery, and early breastfeeding.</p><p class="headingAnchor" id="H2"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>The lifetime prevalence of anaphylaxis in the general population is estimated as 0.05 to 2 percent [<a href="#rid3">3-6</a>]. Data regarding the prevalence among pregnant women are limited. A prospective study from the United Kingdom reported 1.6 cases per 100,000 pregnancies (95% CI 1.1-2.2) [<a href="#rid7">7</a>]. Retrospective studies have found rates of 2.6 to 3.8 per 100,000 pregnancies [<a href="#rid8">8-10</a>]. Risk factors for anaphylaxis during pregnancy were found to be cesarean delivery and a personal history of allergy [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Observations about anaphylaxis during pregnancy, delivery, and breastfeeding are largely derived from case reports and small series [<a href="#rid2">2,8,11-13</a>]. The clinical manifestations of anaphylaxis do not appear to be altered by pregnancy. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a>.)</p><p>The term "anaphylactoid" is no longer recommended for use, and anaphylactic and anaphylactoid reactions do not need to be distinguished with respect to diagnosis and acute treatment [<a href="#rid1">1,6</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Presentation in the pregnant patient</span><span class="headingEndMark"> — </span>Anaphylaxis may present with any combination of approximately 40 symptoms and signs  (<a class="graphic graphic_table graphicRef66333" href="/z/d/graphic/66333.html" rel="external">table 1</a>). Only a few symptoms and signs may be present. Two or more organ systems are typically involved. In pregnant patients, it is particularly important to recognize symptoms and signs that involve the uterus and fetus  (<a class="graphic graphic_figure graphicRef87183" href="/z/d/graphic/87183.html" rel="external">figure 1</a>) [<a href="#rid1">1,2</a>].</p><p>The most common symptoms and signs of anaphylaxis are:</p><p class="bulletIndent1"><span class="glyph">●</span>Cutaneous symptoms, including flushing, itching, urticaria, and angioedema (including periorbital edema and conjunctival swelling).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory symptoms, including nasal discharge, nasal congestion, change in voice quality, sensation of throat closure or choking, cough, wheeze, and dyspnea.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal symptoms, including nausea, vomiting, diarrhea, and crampy abdominal pain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular symptoms, including dizziness, tachycardia, hypotension, and collapse.</p><p></p><p>Anaphylaxis may also present with vulvar and/or vaginal itching, uterine cramping, and lower back pain, presumably as a result of degranulation of mast cells in the walls of the vagina and uterus, which are rich in these cells. Pregnant women have been reported to have contractions following severe allergic reactions and anaphylaxis [<a href="#rid2">2,14</a>]. Symptoms related to reproductive organs generally occur along with symptoms in other organ systems, rather than alone.</p><p class="headingAnchor" id="H5"><span class="h2">Fetus</span><span class="headingEndMark"> — </span>Maternal immunoglobulin E (IgE) does not normally cross the placenta, and, in resource-abundant countries where parasites are not endemic, fetal blood usually does not contain significant amounts of allergen-specific IgE [<a href="#rid11">11</a>]. However, maternal anaphylaxis can lead to fetal hypoxemia, acidosis, hypoxic ischemic encephalopathy, and death if uterine blood flow and maternal oxygenation are significantly compromised. (See <a class="local">'Consequences'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h1">TRIGGERS</span><span class="headingEndMark"> — </span>In a systematic review, beta-lactam antibiotics, latex, and anesthetic agents were the most common triggers [<a href="#rid15">15</a>]. However, any agent that can trigger anaphylaxis in the nonpregnant state can potentially trigger it in a susceptible pregnant person [<a href="#rid2">2,8,12,14</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Antibiotics</span><span class="headingEndMark"> — </span>Antibiotics administered before cesarean delivery for prophylaxis against surgical-site infection or during labor for prophylaxis against early-onset group B streptococcal infection are the most commonly reported triggers of anaphylaxis during pregnancy [<a href="#rid7">7,12,13,16-23</a>]. These medications include penicillin [<a href="#rid12">12,23</a>], <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">ampicillin</a> [<a href="#rid18">18,20,21</a>], <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">cefazolin</a> [<a href="#rid19">19,22</a>], and <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Anesthetic agents</span><span class="headingEndMark"> — </span>Medications used for neuraxial and general anesthesia can cause anaphylaxis [<a href="#rid24">24,25</a>]. Neuromuscular blocking agents, such as suxamethonium, are the most common causes. In a study of anaphylaxis-related mortality in the obstetrical setting from France [<a href="#rid26">26</a>], suxamethonium was a suspected cause in all five pregnant women whose deaths were attributed to anaphylaxis. (See  <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">"Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Neuromuscular-blocking agents'</a>.)</p><p>Local anesthetics used for neuraxial anesthesia can cause vasovagal responses, tachycardia, lightheadedness, metallic taste, and perioral numbness, but these signs and symptoms are more likely the result of accidental intravascular injection rather than an immune-mediated reaction. Anaphylactic reactions to local anesthetics are extremely rare, and true allergic reactions account for less than 1 percent of all drug reactions to local anesthetics. The most common immune-mediated reaction to local anesthetics is a delayed hypersensitivity reaction or contact dermatitis [<a href="#rid27">27,28</a>]. (See  <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">"Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Etiologies'</a> and  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics"</a>.)</p><p class="headingAnchor" id="H873057219"><span class="h2">Oxytocin</span><span class="headingEndMark"> — </span>Anaphylaxis to synthetic <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> (eg, Pitocin, Syntocinon [brand names]) has been reported [<a href="#rid29">29-37</a>]. Positive-immediate (read at 20 minutes) [<a href="#rid33">33</a>], delayed (read at five days) [<a href="#rid32">32</a>], and negative [<a href="#rid31">31</a>] skin tests to oxytocin have been described in these patients. In some cases, the reactions may have been due to concurrent latex exposure [<a href="#rid35">35,36</a>], and, in another case, symptoms may have been attributable to chlorbutol, an "inactive" ingredient in the oxytocin preparation [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H3725474266"><span class="h2">Intravenous iron</span><span class="headingEndMark"> — </span>Intravenous iron is sometimes preferable to oral preparations. The safety of intravenous iron preparations has greatly improved because high-molecular-weight <a class="drug drug_general" data-topicid="8574" href="/z/d/drug information/8574.html" rel="external">iron dextran</a> is no longer available in most of the world. Administration of iron dextran was associated with anaphylaxis and shock, including fatal events. The availability of intravenous iron formulations with improved safety profiles has lowered the threshold at which many clinicians would consider prescribing intravenous iron. (See  <a class="medical medical_review" href="/z/d/html/115637.html" rel="external">"Anemia in pregnancy", section on 'Intravenous iron'</a> and  <a class="medical medical_review" href="/z/d/html/7148.html" rel="external">"Treatment of iron deficiency anemia in adults", section on 'Oral versus IV iron'</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Laminaria</span><span class="headingEndMark"> — </span>Osmotic dilators are used in pregnancy for gradual cervical dilation. <em>Laminaria japonica </em>is a type of osmotic dilator derived from seaweed; it has rarely been associated with anaphylaxis. Conversely, Dilapan-S is a synthetic osmotic dilator made from a polyacrylate-based hydrogel; it has not been associated with hypersensitivity reactions [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H873056598"><span class="h2">Misoprostol</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9657" href="/z/d/drug information/9657.html" rel="external">Misoprostol</a> is a synthetic prostaglandin E1 that causes dissolution of collagen bundles and an increase in the submucosal water content of the cervix, resulting in a cervical state that is associated with greater success when labor is induced with <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a>. Prostaglandins also cause the uterus to contract and may initiate labor. Anaphylaxis following buccal misoprostol administration has been reported [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Natural rubber latex</span><span class="headingEndMark"> — </span>Sensitization to latex appears to occur more frequently in females than in males, and obstetric and gynecologic procedures are common settings for latex anaphylaxis in females in their reproductive years [<a href="#rid39">39,40</a>]. As noted above, <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> and <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">vasopressin</a> may potentiate the effects of latex hypersensitivity in obstetric patients, and homology between latex and oxytocin and vasopressin may play a role [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/5543.html" rel="external">"Latex allergy: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H230899273"><span class="h2">RhD immunoglobulin G (anti-D)</span><span class="headingEndMark"> — </span>Hypersensitivity reactions, including features of anaphylaxis, have occasionally been reported after administration of anti-D immunoglobulin to pregnant women. However, careful evaluation of three cases of suspected anti-D immunoglobulin reactions suggested other causes for their reactions or loss of sensitivity since all three patients were eventually able to tolerate the drug [<a href="#rid42">42</a>]. The investigators proposed using a skin test and drug challenge protocol in patients with suspected anti-D immunoglobulin sensitivity.</p><p class="headingAnchor" id="H13"><span class="h2">Breastfeeding</span><span class="headingEndMark"> — </span>Breastfeeding has been implicated as a trigger of anaphylaxis in several case reports, sometimes in association with the administration of nonsteroidal antiinflammatory drugs, which are also potential anaphylaxis triggers [<a href="#rid43">43-47</a>]. The mechanism underlying breastfeeding anaphylaxis is unclear. Skin testing with <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">oxytocin</a> and breast milk were performed in some of the cases described above, with negative results [<a href="#rid43">43,45</a>]. Changing levels of progesterone and/or prolactin were suggested as possible predisposing factors [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Other</span><span class="headingEndMark"> — </span>As in nonpregnant individuals, venom from stinging Hymenoptera insects (eg, honey bees, yellowjackets, hornets, wasps, or ants, including fire ants) and ingestion of foods (eg, shellfish, peanuts, or tree nuts) can cause anaphylaxis during pregnancy [<a href="#rid48">48-51</a>]. (See  <a class="medical medical_review" href="/z/d/html/4091.html" rel="external">"Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management"</a> and  <a class="medical medical_review" href="/z/d/html/2400.html" rel="external">"Seafood allergies: Fish and shellfish"</a>.)</p><p>Some patients have no obvious trigger and are considered to have idiopathic anaphylaxis. (See  <a class="medical medical_review" href="/z/d/html/387.html" rel="external">"Idiopathic anaphylaxis"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The clinical diagnosis of anaphylaxis during pregnancy is similar to the diagnosis in nonpregnant patients and is based on a meticulous history and physical examination. Diagnostic criteria for anaphylaxis have been defined and validated and can be applied to pregnant patients  (<a class="graphic graphic_table graphicRef72225" href="/z/d/graphic/72225.html" rel="external">table 2</a> and <a class="graphic graphic_figure graphicRef87183" href="/z/d/graphic/87183.html" rel="external">figure 1</a>) [<a href="#rid1">1,2</a>]. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Laboratory tests</span><span class="headingEndMark"> — </span>In some but not all patients, the clinical diagnosis of anaphylaxis can be confirmed by an elevated serum total tryptase level measured in a blood sample drawn shortly after the onset of symptoms. Blood for serum tryptase is optimally obtained 15 minutes to three hours after symptom onset. Any elevation in serum tryptase provides evidence of mast cell activation and thus supports a diagnosis of anaphylaxis, although elevated tryptase levels have also been reported in amniotic fluid embolism [<a href="#rid52">52</a>]. However, in some patients with anaphylaxis, (eg, those with food-triggered anaphylaxis or those who are normotensive), elevations in tryptase generally do not occur. A normal tryptase level cannot be used to refute the diagnosis of anaphylaxis [<a href="#rid2">2,6,53</a>].</p><p>The serum tryptase assay is standardized (in contrast to the histamine assay) and is widely available in clinical laboratories, although results can seldom be obtained on an urgent basis. The interpretation of tryptase levels and other tests that can support the diagnosis of anaphylaxis are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/389.html" rel="external">"Laboratory tests to support the clinical diagnosis of anaphylaxis"</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of anaphylaxis during pregnancy includes all of the disorders that can mimic aspects of anaphylaxis in nonpregnant individuals  (<a class="graphic graphic_table graphicRef65677" href="/z/d/graphic/65677.html" rel="external">table 3</a>), as well as some disorders unique to pregnancy, labor, and delivery  (<a class="graphic graphic_table graphicRef78410" href="/z/d/graphic/78410.html" rel="external">table 4</a>) [<a href="#rid2">2</a>]. The differential diagnosis of anaphylaxis is reviewed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/395.html" rel="external">"Differential diagnosis of anaphylaxis in adults and children"</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Other causes of laryngeal edema</span><span class="headingEndMark"> — </span>Laryngeal obstruction, a frequent and potentially life-threatening symptom of anaphylaxis, must be differentiated from the laryngeal edema associated with preeclampsia, as well as that caused by laryngopathia gravidarum.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preeclampsia</strong> – Laryngeal edema associated with hypertension and proteinuria after 20 weeks gestation suggests preeclampsia. Most cases are asymptomatic and noted at intubation before cesarean delivery. However, difficulty breathing has been described in case reports. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laryngopathia gravidarum</strong> – Laryngopathia gravidarum refers to the changes in laryngeal function observed in pregnancy. In the acute type, symptoms of dyspnea, hoarseness, sore throat, and painful swallowing occur just prior to delivery, and laryngeal examination reveals edema. In the chronic form, the symptoms are similar but begin earlier in pregnancy and persist [<a href="#rid54">54</a>]. (See  <a class="medical medical_review" href="/z/d/html/5552.html" rel="external">"Recognition and management of allergic disease during pregnancy", section on 'Urticaria and angioedema'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hereditary angioedema</strong> – Laryngeal obstruction also occurs in hereditary angioedema (HAE), but laryngeal stridor usually develops over hours rather than minutes. In addition, patients often have a history of recurrent unexplained abdominal pain or episodes of cutaneous swelling. There may also be a family history of HAE. Urticaria (hives) and itching are not present in HAE but are common features of anaphylaxis. (See  <a class="medical medical_review" href="/z/d/html/8103.html" rel="external">"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/8098.html" rel="external">"Hereditary angioedema (due to C1 inhibitor deficiency): Pathogenesis and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H19"><span class="h2">Other causes of hypotension</span><span class="headingEndMark"> — </span>Hypotension may be a prominent feature of severe anaphylaxis and must be differentiated from other causes of hypotension during pregnancy, such as neuraxial block (epidural or spinal), hemorrhage, and amniotic fluid embolism [<a href="#rid2">2</a>]. In hypotensive patients with minimal vaginal bleeding, the possibility of internal hemorrhage should be excluded, especially after operative delivery. The sudden onset of skin symptoms and signs (such as pruritus, urticaria, and angioedema) or respiratory symptoms and signs (such as stridor or wheezing) in addition to hypotension strongly supports a diagnosis of anaphylaxis.</p><p class="headingAnchor" id="H431091899"><span class="h2">Amniotic fluid embolism syndrome</span><span class="headingEndMark"> — </span>Amniotic fluid embolism syndrome is an important cause of acute cardiovascular collapse during pregnancy and can be difficult to distinguish clinically from anaphylaxis. This entity is reviewed briefly here and described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1591.html" rel="external">"Amniotic fluid embolism"</a>.)</p><p class="bulletIndent1">Suggested criteria for amniotic fluid embolism syndrome include one or more of the clinical findings of sudden-onset cardiovascular collapse, respiratory distress, or disseminated intravascular coagulation during pregnancy and absence of other medical explanations for the clinical course.</p><p></p><p>Bronchospasm is characteristic of anaphylaxis rather than amniotic fluid embolism [<a href="#rid55">55</a>], while large volume blood loss should raise suspicion for amniotic fluid embolism. Coagulopathy and/or disseminated intravascular coagulation are more often associated with amniotic fluid embolism, although activation of both the contact system and the coagulation system can also occur in anaphylaxis [<a href="#rid53">53,56</a>].</p><p>Amniotic fluid embolism has been termed "anaphylactoid syndrome of pregnancy" by some authors [<a href="#rid57">57</a>]. The proposed mechanism is a non-IgE-mediated reaction to fetal antigens, leading to mast cell degranulation and release of histamine and tryptase. An elevated beta-tryptase level was reported in one fatal case [<a href="#rid52">52</a>]. Complement activation has also been suggested as a possible mechanism [<a href="#rid58">58</a>]. Blood tests for sialyl-Tn may also be helpful in diagnosis, as this is a possible marker for severe amniotic fluid embolism and appears to be predictive for life-threatening or fatal episodes [<a href="#rid55">55</a>]. Tryptase levels may be increased in amniotic fluid.</p><p class="headingAnchor" id="H20"><span class="h1">CONSEQUENCES</span><span class="headingEndMark"> — </span>Case reports and small series of anaphylaxis during pregnancy generally show good maternal outcomes, although maternal morbidity (eg, abnormal kidney function or kidney failure, increased liver enzymes, disseminated intravascular coagulation, severe hypotension, acute respiratory distress syndrome) and death have been reported [<a href="#rid7">7,12,13,16,26,27,48-50,59,60</a>].</p><p>In contrast, available reports suggest that the fetus/neonate is at risk of neurologic damage and/or death, even when the maternal outcome is favorable [<a href="#rid2">2</a>].</p><p>Maternal blood passing through the uteroplacental interface releases oxygen as a function of the magnitude of the partial pressure of oxygen (PO<sub>2</sub>) difference between the fetal and maternal circulation. The uterine artery is nearly completely dilated to maximize blood flow and oxygen delivery to the fetus. The fetus can compensate for decreased blood flow by increasing oxygen uptake, redistributing circulation to vital organs (brain, heart, adrenal glands, placenta), decreasing gross body movements, and increasing tissue oxygen extraction. However, eventually these compensatory mechanisms can be exceeded, resulting in fetal hypoxemia and acidosis [<a href="#rid61">61,62</a>].</p><p>Maternal anaphylaxis affects the fetus in several ways:</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal hypoxemia directly reduces the oxygen supply for the fetus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maternal hypotension reduces uterine perfusion, which in turn reduces oxygen supply to the fetus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maternal alkalosis decreases uterine blood flow by vasoconstriction and increases the affinity of maternal hemoglobin for oxygen, which reduces the oxygen supply for the fetus.</p><p></p><p>As a result, anaphylaxis may lead to fetal asphyxia or death [<a href="#rid61">61,62</a>]. Neonates may develop rigidity of the extremities, seizure-like movements, brain damage, and/or hypoxic encephalopathy, potentially leading to long-term neurodevelopmental morbidity or death. In most cases, the risk of these consequences can be reduced or eliminated with early recognition of maternal anaphylaxis and prompt administration of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/z/d/html/6205.html" rel="external">"Etiology and pathogenesis of neonatal encephalopathy"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H22"><span class="h2">The pregnant patient</span><span class="headingEndMark"> — </span>With a few modifications, the medical management of anaphylaxis during pregnancy is the same as in nonpregnant patients. Prompt administration of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> is critical. The dosing and route of administration of epinephrine may vary according to the setting:</p><p class="bulletIndent1"><span class="glyph">●</span>In the ambulatory or emergency department setting, <strong>intramuscular</strong> injection of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> is the safest and most effective means of delivery. A brief overview of anaphylaxis treatment is provided in the table  (<a class="graphic graphic_table graphicRef58346" href="/z/d/graphic/58346.html" rel="external">table 5</a>) [<a href="#rid2">2</a>]. A more detailed presentation of the diagnosis and treatment of anaphylaxis is found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment", section on 'Immediate management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the operative setting, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> is usually given by <strong>intravenous</strong> bolus or infusion, using the more dilute preparation intended for intravenous infusion  (<a class="graphic graphic_table graphicRef107933" href="/z/d/graphic/107933.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">"Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Initial management'</a>.)</p><p></p><p class="headingAnchor" id="H2205293713"><span class="h3">Measures specific to pregnant patients</span><span class="headingEndMark"> — </span>There are three modifications to the management of anaphylaxis that are important in pregnant patients [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Positioning the patient on their left side to prevent compression of the aortocaval vessels by the gravid uterus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining a minimum maternal systolic blood pressure of 90 mmHg to maintain adequate uteroplacental perfusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitoring the fetal heart rate to assess the fetal status in response to maternal treatment. (See <a class="local">'Fetal monitoring'</a> below and <a class="local">'Emergency cesarean delivery'</a> below.)</p><p></p><p>Overviews of management in pregnant patients are provided  (<a class="graphic graphic_figure graphicRef87184" href="/z/d/graphic/87184.html" rel="external">figure 2</a> and <a class="graphic graphic_table graphicRef87553" href="/z/d/graphic/87553.html" rel="external">table 7</a>).</p><p class="headingAnchor" id="H23"><span class="h3">Epinephrine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">Epinephrine</a> is considered the drug of choice in the treatment of anaphylaxis in both nonpregnant and pregnant patients [<a href="#rid15">15,63</a>]. No alternative drug more completely treats the physiologic manifestations of anaphylaxis.</p><p>The correct dosing and administration of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> are discussed in more detail separately [<a href="#rid2">2,63-67</a>]. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment", section on 'Epinephrine'</a> and  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment", section on 'Dosing and administration'</a> and  <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">"Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Management'</a>.)</p><p>After the <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection, ambulatory patients should not suddenly sit upright or stand, as this can lead to cardiac arrest due to the empty inferior vena cava/empty ventricle syndrome [<a href="#rid64">64</a>].</p><p>Even though <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> has the potential to reduce uterine blood flow through alpha-adrenergic-mediated blood vessel vasoconstriction [<a href="#rid12">12</a>], evidence of fetal harm in humans is limited and confounded by the disease state necessitating epinephrine administration. </p><p>Infant deaths and neurologic abnormalities have been associated with maternal <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> treatment of anaphylaxis during pregnancy. However, these adverse outcomes are likely due to fetal asphyxia related to severe anaphylaxis itself rather than to epinephrine treatment. Furthermore, healthy infants have been delivered to a number of pregnant women who were treated with epinephrine for anaphylaxis, including one patient who received a continuous intravenous epinephrine infusion for 3.5 hours to treat refractory anaphylaxis during labor [<a href="#rid20">20</a>]. Moreover, perinatal deaths or infant neurologic abnormalities have occurred in women with anaphylaxis who were <strong>not</strong> treated with epinephrine, as described previously.</p><p>A few case reports have suggested <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> by the intravenous route as an alternative to <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> during anaphylaxis in pregnancy [<a href="#rid12">12</a>]. Ephedrine is a noncatechol sympathomimetic with alpha- and beta-adrenergic effects. However, it is a less potent vasoconstrictor and bronchodilator than epinephrine, and its administration has been associated with increased fetal distress and acidosis when compared with other vasopressors [<a href="#rid68">68,69</a>]. Additionally, intravenous formulations of ephedrine are not universally available. Thus, epinephrine remains the recommended agent to treat anaphylaxis during pregnancy.</p><p class="headingAnchor" id="H24"><span class="h3">Supplemental oxygen</span><span class="headingEndMark"> — </span>Supplemental oxygen, 8 to 10 liters by facemask, up to 100 percent, should be administered  (<a class="graphic graphic_table graphicRef87553" href="/z/d/graphic/87553.html" rel="external">table 7</a> and <a class="graphic graphic_figure graphicRef87184" href="/z/d/graphic/87184.html" rel="external">figure 2</a>) [<a href="#rid2">2</a>]. Supplemental oxygen is important because <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, like other alpha-1 adrenergic vasoconstrictors, can potentially worsen the ventilation/perfusion ratio [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H25"><span class="h3">Fluid resuscitation</span><span class="headingEndMark"> — </span>Adequate intravascular volume repletion is important to treat hypotension and maintain uteroplacental perfusion  (<a class="graphic graphic_table graphicRef87553" href="/z/d/graphic/87553.html" rel="external">table 7</a>) [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>The patient should be placed on their left side to prevent added positional hypotension resulting from compression of the aortocaval vessels by the gravid uterus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Impending or existing hypotension must be promptly reversed with large volumes of intravenous fluids, preferably crystalloid (eg, normal [isotonic] <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>) [<a href="#rid70">70</a>]. In nonpregnant adults with anaphylaxis, 1 to 2 liters of normal saline may be needed in the first 30 minutes of treatment. The rate of infusion should be titrated against blood pressure, cardiac rate and function ascertained by continuous noninvasive monitoring, and urine output. Glucose-containing solutions should be avoided, as these fluids can result in a large glucose bolus, which can reduce umbilical cord pH and can cause neonatal hypoglycemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A minimum systolic blood pressure of 90 mmHg should be maintained to ensure adequate placental perfusion and fetal oxygenation since uterine blood flow is not autoregulated.</p><p></p><p class="headingAnchor" id="H26"><span class="h3">Other measures</span><span class="headingEndMark"> — </span>Adjunctive treatments for anaphylaxis include inhaled bronchodilators, H1 antihistamines, H2 antihistamines, and glucocorticoids [<a href="#rid71">71-73</a>]. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchodilators</strong> – A selective beta<sub>2</sub>-adrenergic agonist, such as <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a>, may be administered by nebulizer and facemask if wheezing and/or coughing are prominent symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systematic reviews of H1 antihistamines, H2 antihistamines, and glucocorticoids in anaphylaxis have failed to identify any randomized, controlled trials that meet the inclusion criteria. These medications can be used as add-on treatments in anaphylaxis but should not replace <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> and should not be given as initial treatment or sole treatment in anaphylaxis [<a href="#rid70">70-72</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>H1 antihistamines</strong> – H1 antihistamines treat itching and hives, but these agents do <strong>not</strong> prevent or relieve upper or lower airway obstruction and do <strong>not</strong> prevent or relieve shock and therefore should not be used as initial or sole treatment. The safety of H1 antihistamines in pregnancy was affirmed in a meta-analysis that examined the association between antihistamine use and major congenital malformations [<a href="#rid74">74</a>]. In this review of 24 controlled studies, including over 200,000 first trimester exposures, exposure to H1 antihistamines was associated with a lower risk of malformations (odds ratio [OR] 0.76, 95% CI 0.60-0.94). In most cases, the H1 antihistamines were being taken to treat nausea and vomiting of pregnancy.</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">Diphenhydramine</a> (50 mg intravenously) can be given to decrease hives and itching if a parenteral agent is desired. No second-generation H1 antihistamine is available in a parenteral formulation.</p><p></p><p class="bulletIndent2">Among oral agents, the second-generation H1 antihistamines, <a class="drug drug_general" data-topicid="9236" href="/z/d/drug information/9236.html" rel="external">cetirizine</a> and <a class="drug drug_general" data-topicid="9572" href="/z/d/drug information/9572.html" rel="external">loratadine</a>, are preferred over other oral H1 antihistamines for use in pregnancy because of reassuring pregnancy safety data and because second-generation agents are significantly less likely to impair central nervous system function and cause sedation or other adverse effects [<a href="#rid75">75</a>]. Loratadine (and other nonimpairing, nonsedating H1 antihistamines) are minimally excreted in breast milk [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>H2 antihistamines</strong> – H2 antihistamines, in combination with H1 antihistamines, decrease skin symptoms and signs but are not lifesaving [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Glucocorticoids</strong> – A glucocorticoid (eg, <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> 1 mg/kg intravenously every eight hours for two or three doses) can be administered to patients with severe anaphylaxis to reduce the risk of protracted anaphylaxis, although efficacy is unproven, and doses are extrapolated from asthma treatment [<a href="#rid72">72</a>].</p><p></p><p class="headingAnchor" id="H27"><span class="h2">Fetal monitoring</span><span class="headingEndMark"> — </span>In addition to continuous electronic monitoring of the patient's heart rate, blood pressure, electrocardiogram, and oxygenation, we suggest continuous electronic fetal heart monitoring of potentially viable fetuses in pregnancies complicated by anaphylaxis. Fetal heart rate monitoring can be a more sensitive assessment of maternal cardiorespiratory status than parental vital signs, as parental hemodynamic stability does not guarantee that placental perfusion and fetal oxygenation are optimal [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/418.html" rel="external">"Intrapartum fetal heart rate monitoring: Overview"</a>.)</p><p>Nonreassuring fetal heart rate patterns (category II and III fetal heart rate tracings) during anaphylaxis are managed by correcting parental hypotension and/or hypoxemia with aggressive medical management of the pregnant patient. However, achieving stable parental hemodynamic status does not guarantee appropriate placental perfusion and fetal oxygenation, so the abnormal pattern may persist and necessitate cesarean delivery [<a href="#rid27">27</a>] (see <a class="local">'Emergency cesarean delivery'</a> below). If the abnormal fetal heart rate pattern resolves, it has been recommended that continuous fetal monitoring be continued for 48 to 72 hours following anaphylaxis [<a href="#rid60">60</a>].</p><p class="headingAnchor" id="H4132116117"><span class="h2">Emergency cesarean delivery</span><span class="headingEndMark"> — </span>Emergency cesarean delivery should be considered in the setting of a nonreassuring fetal heart rate tracing that is unresponsive to parental and fetal resuscitative interventions [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/16663.html" rel="external">"Intrapartum category I, II, and III fetal heart rate tracings: Management", section on 'General approach'</a>.)</p><p>Cesarean delivery can have beneficial parental effects because emptying the uterus when the fundus reaches or exceeds the level of the umbilicus reduces aortocaval compression and increases cardiac output. In the case of maternal cardiac arrest, the goal is delivery of the fetus within five minutes of arrest (see  <a class="medical medical_review" href="/z/d/html/14184.html" rel="external">"Sudden cardiac arrest and death in pregnancy", section on 'Delivery as part of the resuscitation process'</a>). However, the potential benefits of emergency cesarean delivery in patients with anaphylaxis refractory to medical treatment need to be balanced against the potential parental risks of surgery in an unstable patient with hypoxemia, and/or hypotension [<a href="#rid2">2</a>]. In addition, the potential benefits should be balanced against neonatal morbidity and mortality secondary to prematurity when the gestation is remote from term [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H3337479046"><span class="h2">Refractory anaphylaxis</span><span class="headingEndMark"> — </span>Patients with anaphylaxis that is not responding completely to initial management should be admitted to an intensive care unit without delay. There are no published prospective studies on the optimal management of anaphylaxis with hypotension refractory to initial treatment with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> and intravenous fluid resuscitation.</p><p>Anaphylactic shock displays features of both distributive (vasodilatory) and hypovolemic shock. The management of severe forms of these types of shock is discussed separately. A systematic review of crystalloids versus colloids in fluid resuscitation based on mortality data from randomized, controlled trials in more than 20,000 critically ill surgical patients has revealed that colloid administration does not correlate with increased survival in distributive shock [<a href="#rid70">70</a>]. (See  <a class="medical medical_review" href="/z/d/html/6395.html" rel="external">"Sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6389.html" rel="external">"Hypovolemic shock in children in resource-abundant settings: Initial evaluation and management"</a> and  <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">"Evaluation and management of suspected sepsis and septic shock in adults", section on 'Vasopressors'</a> and  <a class="medical medical_review" href="/z/d/html/1607.html" rel="external">"Treatment of severe hypovolemia or hypovolemic shock in adults"</a>.)</p><p class="headingAnchor" id="H29"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Strategies for the prevention of anaphylaxis during pregnancy primarily involve identification, confirmation, and avoidance of the specific allergen triggers to which the patient is sensitive, including foods, medications, insect stings, and natural rubber latex. This begins with a thorough medical history, as described below. Patients with histories of reactions to latex or agents that may be required during pregnancy (eg, beta-lactam antibiotics, local anesthetics, or neuromuscular blocking drugs) should be referred to an allergy specialist for evaluation, ideally <strong>before</strong> pregnancy, so that testing and challenge procedures can be done, if needed [<a href="#rid2">2</a>]. Most allergists defer noncritical skin testing in pregnant patients until after delivery.</p><p class="headingAnchor" id="H30"><span class="h2">Patients with drug allergies</span><span class="headingEndMark"> — </span>Pregnant patients should be questioned carefully about past adverse drug reactions. Specific questions that help uncover important information about past reactions are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/2079.html" rel="external">"An approach to the patient with drug allergy", section on 'Clinical history'</a>.)</p><p>Patients with a history of adverse reactions to penicillins who need these drugs can be managed in several ways:</p><p class="bulletIndent1"><span class="glyph">●</span>If this history is obtained in advance, referral to an allergy specialist should be arranged. Skin testing and graded challenge have traditionally been avoided during pregnancy because of the small but definite risk that the procedure can induce a systemic allergic reaction. However, two studies of 136 and 220 pregnant women who underwent penicillin testing concluded that penicillin allergy skin testing and challenge was safe during pregnancy [<a href="#rid77">77,78</a>]. In exceptional circumstances, desensitization has also been safely performed in pregnant women [<a href="#rid79">79,80</a>]. One scenario in which this is indicated is the need to administer penicillin to a penicillin-allergic pregnant woman for treatment of syphilis and prevention of congenital syphilis [<a href="#rid81">81</a>]. (See  <a class="medical medical_review" href="/z/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Role of nonpenicillin regimens'</a>.)</p><p></p><p class="bulletIndent1">Another situation in which possible penicillin allergy in a pregnant patient requires careful consideration is the need to treat following a positive culture for group B <em>Streptococcus</em>. This is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Patients with penicillin allergy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If referral to an allergist or skin testing is not possible, an antibiotic that does not cross-react with the suspect culprit antibiotic should be given. (See  <a class="medical medical_review" href="/z/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Patients with penicillin allergy'</a>.)</p><p></p><p class="headingAnchor" id="H31"><span class="h2">Patients with natural rubber latex allergy</span><span class="headingEndMark"> — </span>Pregnant patients should be questioned about possible latex allergy and about past reactions to common latex-containing objects [<a href="#rid82">82</a>]. These objects include latex gloves, balloons, condoms, pacifiers, teethers, bottle nipples, and adhesives for hair extensions. Objects commonly used in medical procedures include latex gloves, balloon-tipped catheters (eg, used during <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">barium</a> enema examination, pulmonary artery catheterization), and dental cofferdams. (See  <a class="medical medical_review" href="/z/d/html/5543.html" rel="external">"Latex allergy: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>The management of patients with latex allergy primarily involves the provision of care in a latex-free environment. (See  <a class="medical medical_review" href="/z/d/html/5554.html" rel="external">"Latex allergy: Management"</a>.)</p><p class="headingAnchor" id="H32"><span class="h2">Patients with insect sting allergy</span><span class="headingEndMark"> — </span>Patients with possible systemic allergic reactions to insect stings (eg, honey bees, yellowjackets, hornets, and wasps ) should be evaluated by an allergy specialist to see if they are candidates for immunotherapy with standardized stinging insect venom (VIT). VIT involves a series of subcutaneous injections with standardized insect venoms administered over a period of three to five years. It significantly reduces the patient's risk of anaphylaxis or other systemic reactions to stinging insect venom and provides protection for years after injections are discontinued [<a href="#rid2">2,83</a>].</p><p>Tests for VIT and initiation of VIT are not typically performed during pregnancy due to the small but definite risk of anaphylaxis during the initial dose escalation. However, if a patient becomes pregnant while receiving maintenance VIT, when doses are not changing, it may be safely continued [<a href="#rid2">2</a>]. VIT is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4090.html" rel="external">"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action", section on 'Pregnant women'</a>.)</p><p class="headingAnchor" id="H33"><span class="h2">Emergency preparedness</span><span class="headingEndMark"> — </span>Pregnant patients who are at risk of anaphylaxis in the community setting should be counseled to take the following precautions [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Carry one or more <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> autoinjectors at all times. Patients should be trained in how to use an epinephrine autoinjector correctly and when to use it [<a href="#rid67">67</a>]. (See  <a class="medical medical_review" href="/z/d/html/388.html" rel="external">"Prescribing epinephrine for anaphylaxis self-treatment"</a> and  <a class="medical medical_patient" href="/z/d/html/365.html" rel="external">"Patient education: Using an epinephrine autoinjector (Beyond the Basics)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Carry an anaphylaxis emergency action plan at all times. This document should be developed with input from the patient and should describe the importance of prompt intramuscular injection of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, laying the patient on their left side, and calling 911 or emergency medical services <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.aaaai.org%2FAaaai%2Fmedia%2FMediaLibrary%2FPDF+Documents%2FLibraries%2FAnaphylaxis-Emergency-Action-Plan.pdf&amp;token=%2FC5Q%2FiCB%2F2LLCwV7T8HK2lwm6sR%2FkEZoNaIqN%2F73HXSOVycSIPyputPn68SH00rxz4XgltVFJ9rSmMATkiTNtTCeVQHr44rjlSZkcJVXEDbh%2Bx3d7qqBZUqDAak3uoXk%2FI0U9CKYd1MPL7MRKdB8kw%3D%3D&amp;TOPIC_ID=393" target="_blank">(Anaphylaxis Emergency Action Plan - English)</a> <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.aaaai.org%2FAaaai%2Fmedia%2FMediaLibrary%2FPDF+Documents%2FSpanish%2FAnaphylaxis-Emergency-Action-Plan-Spanish.pdf&amp;token=Ls%2BBUTXwAuTJRkpRQ4LA1JgGv03onx4w09YFWrjDcTMb8nQK70M4sv3yKBB6Ojk%2FBSHuni4YwWs1wy9vgRTN0JU2OPH9WbcbiuH8WjlQ7CNVIxv%2FGWSD5R2OrOOaPAI%2FdBm3AtkXm1l5Bk3m72nDvg%3D%3D&amp;TOPIC_ID=393" target="_blank">(Anaphylaxis Emergency Action Plan - Spanish)</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obtain a medical identification bracelet or necklace listing their known allergies and any relevant comorbidities (eg, asthma, cardiovascular conditions, mastocytosis, or idiopathic mast cell activation syndrome).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provide <strong>all</strong> of their health care providers with documentation of known allergies and any relevant comorbidities.</p><p></p><p>In addition, referral to an allergy specialist should be arranged. The immediate and long-term care of patients with anaphylaxis is presented in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment", section on 'Follow-up care'</a> and  <a class="medical medical_review" href="/z/d/html/391.html" rel="external">"Anaphylaxis: Confirming the diagnosis and determining the cause(s)"</a>.)</p><p class="headingAnchor" id="H224114511"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/105526.html" rel="external">"Society guideline links: Anaphylaxis"</a>.)</p><p class="headingAnchor" id="H34"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – Anaphylaxis is not common during pregnancy. However, it is important to recognize it rapidly and treat it effectively as the parental hypoxia and hypotension that can result may be catastrophic to both parent and fetus. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Anaphylaxis may present with various combinations of up to 40 potential symptoms and signs  (<a class="graphic graphic_table graphicRef66333" href="/z/d/graphic/66333.html" rel="external">table 1</a>). Common features include pruritus (sometimes involving the vagina and vulva), urticaria, angioedema, bronchospasm, tachycardia, and hypotension. In pregnant patients, anaphylaxis may also induce lower back pain, uterine cramping, nonreassuring fetal heart rate, and preterm labor  (<a class="graphic graphic_figure graphicRef87183" href="/z/d/graphic/87183.html" rel="external">figure 1</a>). Fetal asphyxia, hypoxic ischemic encephalopathy, or death can occur. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies</strong> – Triggers of anaphylaxis in pregnancy include those that typically induce it in community settings (eg, foods, drugs, or insect stings) and those that are specifically encountered in medical settings, including labor and delivery, such as latex, antibiotics, and neuromuscular blocking drugs. Rarely, breastfeeding may also trigger anaphylaxis. (See <a class="local">'Triggers'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and differential diagnosis</strong> – The diagnosis of anaphylaxis in pregnancy is based on the clinical history and on physical signs  (<a class="graphic graphic_table graphicRef72225" href="/z/d/graphic/72225.html" rel="external">table 2</a>). It is sometimes confirmed by laboratory tests, such as an elevated serum total tryptase level. However, a tryptase level that is within normal limits cannot be used to refute the diagnosis. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact on the fetus</strong> – Parental hypoxemia and hypotension in anaphylaxis are associated with a high risk of fetal asphyxia or death, even when the parental outcome is favorable. (See <a class="local">'Consequences'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Importance of </strong><strong>epinephrine</strong> – Medical management of anaphylaxis in a pregnant patient is similar to that in the nonpregnant patient and involves prompt intramuscular or intravenous injection of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, adequate supplemental oxygen, and intravenous fluid resuscitation  (<a class="graphic graphic_table graphicRef87553" href="/z/d/graphic/87553.html" rel="external">table 7</a> and <a class="graphic graphic_figure graphicRef87184" href="/z/d/graphic/87184.html" rel="external">figure 2</a>). The fetal heart rate should be monitored if the fetus has reached a viable gestational age. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Prevention of anaphylaxis during pregnancy begins with a careful history to uncover any past allergic reactions that may provide clues about potential allergies to foods, medications, insect stings, latex, or other allergens. Patients with past anaphylaxis should prepare for a potential recurrence (ie, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> autoinjector, anaphylaxis emergency action plan, and medical identification). (See <a class="local">'Prevention'</a> above.)</p><p></p><p class="headingAnchor" id="H455170249"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges F Estelle R Simons, MD, FRCPC, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.</a></li><li><a class="nounderline abstract_t">Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130:597.</a></li><li><a class="nounderline abstract_t">Wood RA, Camargo CA Jr, Lieberman P, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133:461.</a></li><li><a class="nounderline abstract_t">Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122:1161.</a></li><li><a class="nounderline abstract_t">Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006; 97:596.</a></li><li><a class="nounderline abstract_t">Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010; 125:S161.</a></li><li><a class="nounderline abstract_t">McCall SJ, Bunch KJ, Brocklehurst P, et al. The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population-based descriptive study. BJOG 2018; 125:965.</a></li><li><a class="nounderline abstract_t">Mulla ZD, Ebrahim MS, Gonzalez JL. Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database. Ann Allergy Asthma Immunol 2010; 104:55.</a></li><li class="breakAll">Lewis G.. The Confidential Enquiry into Maternal and Child Health (CEMACH): Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer (2003-2005). The Seventh Report on CEMACH in the United Kingdom; London, 2007.</li><li><a class="nounderline abstract_t">McCall SJ, Kurinczuk JJ, Knight M. Anaphylaxis in Pregnancy in the United States: Risk Factors and Temporal Trends Using National Routinely Collected Data. J Allergy Clin Immunol Pract 2019; 7:2606.</a></li><li class="breakAll">Smith PH, Ownby DR. Clinical significance of immunoglobulin E. In: Middleton's Allergy Principles and Practice, 8th ed, Adkinson NF, Bochner BS, Burks AW (Eds), Saunders, Philadelphia 2014. p.1108.</li><li><a class="nounderline abstract_t">Chaudhuri K, Gonzales J, Jesurun CA, et al. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth 2008; 17:350.</a></li><li><a class="nounderline abstract_t">Sengupta A, Kohli JK. Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death. J Obstet Gynaecol Res 2008; 34:252.</a></li><li><a class="nounderline abstract_t">Romero R, Kusanovic JP, Muñoz H, et al. Allergy-induced preterm labor after the ingestion of shellfish. J Matern Fetal Neonatal Med 2010; 23:351.</a></li><li><a class="nounderline abstract_t">Carra S, Schatz M, Mertes PM, et al. Anaphylaxis and Pregnancy: A Systematic Review and Call for Public Health Actions. J Allergy Clin Immunol Pract 2021; 9:4270.</a></li><li><a class="nounderline abstract_t">Khan R, Anastasakis E, Kadir RA. Anaphylactic reaction to ceftriaxone in labour. An emerging complication. J Obstet Gynaecol 2008; 28:751.</a></li><li><a class="nounderline abstract_t">Gallagher JS. Anaphylaxis in pregnancy. Obstet Gynecol 1988; 71:491.</a></li><li><a class="nounderline abstract_t">Heim K, Alge A, Marth C. Anaphylactic reaction to ampicillin and severe complication in the fetus. Lancet 1991; 337:859.</a></li><li><a class="nounderline abstract_t">Konno R, Nagase S. Anaphylactic reaction to cefazolin in pregnancy. J Obstet Gynaecol (Tokyo 1995) 1995; 21:577.</a></li><li><a class="nounderline abstract_t">Gei AF, Pacheco LD, Vanhook JW, Hankins GD. The use of a continuous infusion of epinephrine for anaphylactic shock during labor. Obstet Gynecol 2003; 102:1332.</a></li><li><a class="nounderline abstract_t">Berardi A, Rossi K, Cavalleri F, et al. Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis. J Perinat Med 2004; 32:375.</a></li><li><a class="nounderline abstract_t">Jao MS, Cheng PJ, Shaw SW, Soong YK. Anaphylaxis to cefazolin during labor secondary to prophylaxis for group B Streptococcus: a case report. J Reprod Med 2006; 51:655.</a></li><li><a class="nounderline abstract_t">Sheikh J. Intrapartum anaphylaxis to penicillin in a woman with rheumatoid arthritis who had no prior penicillin allergy. Ann Allergy Asthma Immunol 2007; 99:287.</a></li><li><a class="nounderline abstract_t">Edmondson WC, Skilton RW. Anaphylaxis in pregnancy--the right treatment? Anaesthesia 1994; 49:454.</a></li><li><a class="nounderline abstract_t">Baraka A, Sfeir S. Anaphylactic cardiac arrest in a parturient. Response of the newborn. JAMA 1980; 243:1745.</a></li><li><a class="nounderline abstract_t">Tacquard C, Chassard D, Malinovsky JM, et al. Anaphylaxis-related mortality in the obstetrical setting: analysis of the French National Confidential Enquiry into Maternal Deaths from 2001 to 2012. Br J Anaesth 2019; 123:e151.</a></li><li><a class="nounderline abstract_t">Hepner DL, Castells M, Mouton-Faivre C, Dewachter P. Anaphylaxis in the clinical setting of obstetric anesthesia: a literature review. Anesth Analg 2013; 117:1357.</a></li><li><a class="nounderline abstract_t">Adriaensens I, Vercauteren M, Soetens F, et al. Allergic reactions during labour analgesia and caesarean section anaesthesia. Int J Obstet Anesth 2013; 22:231.</a></li><li><a class="nounderline abstract_t">Lin MC, Hsieh TK, Liu CA, et al. Anaphylactoid shock induced by oxytocin administration--a case report. Acta Anaesthesiol Taiwan 2007; 45:233.</a></li><li><a class="nounderline abstract_t">Shimo T, Nishiike S, Masuoka M, et al. [Intraoperative anaphylactic shock induced by methylergometrine and oxytocin]. Masui 2006; 55:447.</a></li><li><a class="nounderline abstract_t">Slater RM, Bowles BJ, Pumphrey RS. Anaphylactoid reaction to oxytocin in pregnancy. Anaesthesia 1985; 40:655.</a></li><li><a class="nounderline abstract_t">Emmott RS. Recurrent anaphylactoid reaction during caesarean section. Anaesthesia 1990; 45:62.</a></li><li><a class="nounderline abstract_t">Pant D, Vohra VK, Pandey SS, Sood J. Pulseless electrical activity during caesarean delivery under spinal anaesthesia: a case report of severe anaphylactic reaction to Syntocinon. Int J Obstet Anesth 2009; 18:85.</a></li><li><a class="nounderline abstract_t">Cabestrero D, Pérez-Paredes C, Fernández-Cid R, Arribas MA. Bronchospasm and laryngeal stridor as an adverse effect of oxytocin treatment. Crit Care 2003; 7:392.</a></li><li><a class="nounderline abstract_t">Morriss WW, Lavies NG, Anderson SK, Southgate HJ. Acute respiratory distress during caesarean section under spinal anaesthesia. A probable case of anaphylactoid reaction to Syntocinon. Anaesthesia 1994; 49:41.</a></li><li><a class="nounderline abstract_t">Ogata J, Minami K. Synthetic oxytocin and latex allergy. Br J Anaesth 2007; 98:845.</a></li><li><a class="nounderline abstract_t">Schoen C, Campbell S, Maratas A, Kim C. Anaphylaxis to buccal misoprostol for labor induction. Obstet Gynecol 2014; 124:466.</a></li><li><a class="nounderline abstract_t">Sierra T, Figueroa MM, Chen KT, et al. Hypersensitivity to laminaria: a case report and review of literature. Contraception 2015; 91:353.</a></li><li><a class="nounderline abstract_t">Eckhout GV Jr, Ayad S. Anaphylaxis due to airborne exposure to latex in a primigravida. Anesthesiology 2001; 95:1034.</a></li><li><a class="nounderline abstract_t">Draisci G, Nucera E, Pollastrini E, et al. Anaphylactic reactions during cesarean section. Int J Obstet Anesth 2007; 16:63.</a></li><li><a class="nounderline abstract_t">Shum M, Ren Z, Achar K, Jerschow E. Intraoperative anaphylaxis to latex possibly facilitated by the administration of oxytocin and vasopressin. J Allergy Clin Immunol Pract 2016; 4:773.</a></li><li><a class="nounderline abstract_t">Rutkowski K, Nasser SM. Management of hypersensitivity reactions to anti-D immunoglobulin preparations. Allergy 2014; 69:1560.</a></li><li><a class="nounderline abstract_t">Mullins RJ, Russell A, McGrath GJ, et al. Breastfeeding anaphylaxis. Lancet 1991; 338:1279.</a></li><li><a class="nounderline abstract_t">MacDonell JW, Ito S. Breastfeeding anaphylaxis case study. J Hum Lact 1998; 14:243.</a></li><li><a class="nounderline abstract_t">Shank JJ, Olney SC, Lin FL, McNamara MF. Recurrent postpartum anaphylaxis with breast-feeding. Obstet Gynecol 2009; 114:415.</a></li><li><a class="nounderline abstract_t">Villalta D, Martelli P. A case of breastfeeding anaphylaxis. Eur Ann Allergy Clin Immunol 2007; 39:26.</a></li><li><a class="nounderline abstract_t">McKinney KK, Scranton SE. A case report of breastfeeding anaphylaxis: successful prophylaxis with oral antihistamines. Allergy 2011; 66:435.</a></li><li><a class="nounderline abstract_t">Habek D, Cerkez-Habek J, Jalsovec D. Anaphylactic shock in response to wasp sting in pregnancy. Zentralbl Gynakol 2000; 122:393.</a></li><li><a class="nounderline abstract_t">Rizk DE, Mensah-Brown E, Lukic M. Placental abruption and intrauterine death following an ant sting. Int J Gynaecol Obstet 1998; 63:71.</a></li><li><a class="nounderline abstract_t">Klein VR, Harris AP, Abraham RA, Niebyl JR. Fetal distress during a maternal systemic allergic reaction. Obstet Gynecol 1984; 64:15S.</a></li><li><a class="nounderline abstract_t">Erasmus C, Blackwood W, Wilson J. Infantile multicystic encephalomalacia after maternal bee sting anaphylaxis during pregnancy. Arch Dis Child 1982; 57:785.</a></li><li><a class="nounderline abstract_t">Farrar SC, Gherman RB. Serum tryptase analysis in a woman with amniotic fluid embolism. A case report. J Reprod Med 2001; 46:926.</a></li><li><a class="nounderline abstract_t">Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007; 120:S2.</a></li><li><a class="nounderline abstract_t">Bhatia PL, Singh MS, Jha BK. Laryngopathia gravidarum. Ear Nose Throat J 1981; 60:408.</a></li><li><a class="nounderline abstract_t">Harboe T, Benson MD, Oi H, et al. Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. Acta Anaesthesiol Scand 2006; 50:324.</a></li><li><a class="nounderline abstract_t">Kishimoto TK, Viswanathan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008; 358:2457.</a></li><li><a class="nounderline abstract_t">Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172:1158.</a></li><li><a class="nounderline abstract_t">Benson MD, Kobayashi H, Silver RK, et al. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 2001; 97:510.</a></li><li><a class="nounderline abstract_t">Suri S, Salfield S, Baxter P. Congenital paraplegia following maternal hypotension. Dev Med Child Neurol 1999; 41:273.</a></li><li><a class="nounderline abstract_t">Berenguer A, Couto A, Brites V, Fernandes R. Anaphylaxis in pregnancy: a rare cause of neonatal mortality. BMJ Case Rep 2013; 2013.</a></li><li><a class="nounderline abstract_t">Cousins L. Fetal oxygenation, assessment of fetal well-being, and obstetric management of the pregnant patient with asthma. J Allergy Clin Immunol 1999; 103:S343.</a></li><li class="breakAll">Cousins L, Catanzarite VA. Fetal oxygenation, acid-base balance, and assessment of well-being in the pregnancy complicated by asthma or anaphylaxis. In: Asthma and immunological diseases in pregnancy and early infancy, Schatz M, Zeiger RS, Claman HN (Eds), Marcel Dekker, New York 1998. p.27.</li><li><a class="nounderline abstract_t">Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 2009; 64:204.</a></li><li><a class="nounderline abstract_t">Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112:451.</a></li><li class="breakAll">Epinephrine. In: Drugs in Pregnancy and Latation, 8th edition, Briggs GG, Freeman RK, Yaffe SJ (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. p.637.</li><li><a class="nounderline abstract_t">Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 2010; 10:354.</a></li><li><a class="nounderline abstract_t">Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract 2015; 3:76.</a></li><li class="breakAll">Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 12th ed, Brunton LL, Chabner BA, Knollmann BC (Eds), McGraw-Hill Companies, New York 2011. p.277.</li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Tan PE, et al. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 2009; 111:506.</a></li><li><a class="nounderline abstract_t">Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; :CD000567.</a></li><li><a class="nounderline abstract_t">Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62:830.</a></li><li><a class="nounderline abstract_t">Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2012; :CD007596.</a></li><li><a class="nounderline abstract_t">Nurmatov UB, Rhatigan E, Simons FE, Sheikh A. H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol 2014; 112:126.</a></li><li><a class="nounderline abstract_t">Gilboa SM, Ailes EC, Rai RP, et al. Antihistamines and birth defects: a systematic review of the literature. Expert Opin Drug Saf 2014; 13:1667.</a></li><li><a class="nounderline abstract_t">Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011; 128:1139.</a></li><li><a class="nounderline abstract_t">Hilbert J, Radwanski E, Affrime MB, et al. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988; 28:234.</a></li><li><a class="nounderline abstract_t">Wolfson AR, Mancini CM, Banerji A, et al. Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use. J Allergy Clin Immunol Pract 2021; 9:1338.</a></li><li><a class="nounderline abstract_t">Patel V, Gleeson PK, Delaney K, et al. Safety and outcomes of penicillin allergy evaluation in pregnant women. Ann Allergy Asthma Immunol 2022; 128:568.</a></li><li><a class="nounderline abstract_t">Wendel GD Jr, Stark BJ, Jamison RB, et al. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312:1229.</a></li><li><a class="nounderline abstract_t">Chisholm CA, Katz VL, McDonald TL, Bowes WA Jr. Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol 1997; 14:553.</a></li><li><a class="nounderline abstract_t">Galvao TF, Silva MT, Serruya SJ, et al. Safety of benzathine penicillin for preventing congenital syphilis: a systematic review. PLoS One 2013; 8:e56463.</a></li><li><a class="nounderline abstract_t">Péer L, Brezis ML, Shalit M, et al. Evaluation of a prospectively administered written questionnaire to reduce the incidence of suspected latex anaphylaxis during elective cesarean delivery. Int J Obstet Anesth 2014; 23:335.</a></li><li><a class="nounderline abstract_t">Boyle RJ, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012; 10:CD008838.</a></li></ol></div><div id="topicVersionRevision">Topic 393 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16461139" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22871389" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Anaphylaxis during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24144575" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18992928" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17165265" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20176258" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29193647" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population-based descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20143646" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20143646" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31102701" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Anaphylaxis in Pregnancy in the United States: Risk Factors and Temporal Trends Using National Routinely Collected Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31102701" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Anaphylaxis in Pregnancy in the United States: Risk Factors and Temporal Trends Using National Routinely Collected Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18691872" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Anaphylactic shock in pregnancy: a case study and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18412791" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19900031" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Allergy-induced preterm labor after the ingestion of shellfish.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34365055" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Anaphylaxis and Pregnancy: A Systematic Review and Call for Public Health Actions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19065378" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Anaphylactic reaction to ceftriaxone in labour. An emerging complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3347441" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Anaphylaxis in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1672954" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Anaphylactic reaction to ampicillin and severe complication in the fetus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8640468" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Anaphylactic reaction to cefazolin in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14662223" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The use of a continuous infusion of epinephrine for anaphylactic shock during labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15346827" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16967637" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Anaphylaxis to cefazolin during labor secondary to prophylaxis for group B Streptococcus: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17910335" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Intrapartum anaphylaxis to penicillin in a woman with rheumatoid arthritis who had no prior penicillin allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8210005" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Anaphylaxis in pregnancy--the right treatment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7365941" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Anaphylactic cardiac arrest in a parturient. Response of the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30915993" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Anaphylaxis-related mortality in the obstetrical setting: analysis of the French National Confidential Enquiry into Maternal Deaths from 2001 to 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24257386" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Anaphylaxis in the clinical setting of obstetric anesthesia: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23711758" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Allergic reactions during labour analgesia and caesarean section anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18251245" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Anaphylactoid shock induced by oxytocin administration--a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16634548" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : [Intraoperative anaphylactic shock induced by methylergometrine and oxytocin].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4025768" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Anaphylactoid reaction to oxytocin in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2316848" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Recurrent anaphylactoid reaction during caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19111230" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Pulseless electrical activity during caesarean delivery under spinal anaesthesia: a case report of severe anaphylactic reaction to Syntocinon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12974972" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Bronchospasm and laryngeal stridor as an adverse effect of oxytocin treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8311212" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Acute respiratory distress during caesarean section under spinal anaesthesia. A probable case of anaphylactoid reaction to Syntocinon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17519267" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Synthetic oxytocin and latex allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25004314" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Anaphylaxis to buccal misoprostol for labor induction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25595541" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Hypersensitivity to laminaria: a case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11605905" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Anaphylaxis due to airborne exposure to latex in a primigravida.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17126012" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Anaphylactic reactions during cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27039235" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intraoperative anaphylaxis to latex possibly facilitated by the administration of oxytocin and vasopressin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25066207" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Management of hypersensitivity reactions to anti-D immunoglobulin preparations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1682680" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Breastfeeding anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10205437" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Breastfeeding anaphylaxis case study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19622944" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Recurrent postpartum anaphylaxis with breast-feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17375739" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A case of breastfeeding anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21284652" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A case report of breastfeeding anaphylaxis: successful prophylaxis with oral antihistamines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10951712" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Anaphylactic shock in response to wasp sting in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9849718" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Placental abruption and intrauterine death following an ant sting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6472743" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Fetal distress during a maternal systemic allergic reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7138068" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Infantile multicystic encephalomalacia after maternal bee sting anaphylaxis during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11725740" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Serum tryptase analysis in a woman with amniotic fluid embolism. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17602945" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Risk assessment in anaphylaxis: current and future approaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7318714" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Laryngopathia gravidarum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16480466" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18434646" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Contaminated heparin associated with adverse clinical events and activation of the contact system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7726251" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Amniotic fluid embolism: analysis of the national registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11275019" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Immunologic studies in presumed amniotic fluid embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10355814" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Congenital paraplegia following maternal hypotension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23314874" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Anaphylaxis in pregnancy: a rare cause of neonatal mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9949335" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Fetal oxygenation, assessment of fetal well-being, and obstetric management of the pregnant patient with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9949335" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Fetal oxygenation, assessment of fetal well-being, and obstetric management of the pregnant patient with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19178399" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Adrenaline for the treatment of anaphylaxis: cochrane systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12897756" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Fatal posture in anaphylactic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12897756" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Fatal posture in anaphylactic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20543673" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Epinephrine and its use in anaphylaxis: current issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25577622" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25577622" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19672175" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23450531" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Colloids versus crystalloids for fluid resuscitation in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17620060" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22513951" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Glucocorticoids for the treatment of anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24468252" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25307228" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Antihistamines and birth defects: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22035879" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Histamine and H1-antihistamines: celebrating a century of progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2966185" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Excretion of loratadine in human breast milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33212237" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35123076" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Safety and outcomes of penicillin allergy evaluation in pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3921835" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Penicillin allergy and desensitization in serious infections during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9394165" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Penicillin desensitization in the treatment of syphilis during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23437138" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Safety of benzathine penicillin for preventing congenital syphilis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25201315" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Evaluation of a prospectively administered written questionnaire to reduce the incidence of suspected latex anaphylaxis during elective cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23076950" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Venom immunotherapy for preventing allergic reactions to insect stings.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
